Home / News / SHL Medical / SHL Medical to attend Pharma 2022
Events| September 09, 2022

SHL Medical to attend Pharma 2022

Shl Medical To Attend Pharma 2022
Participating for the first time, SHL Medical will be exhibiting at Booth #22

This October, SHL Medical will participate for the first time in Pharma 2022. The event will be held in Nice, France on October 11-13. Our business representatives will be ready to welcome and interact with visitors at Booth #22.

As one of the leading solution providers of drug delivery systems, SHL has been in the forefront of the industry. Pharma 2022 is an ideal platform to showcase how we have been setting trends for autoinjector usability and shaping standards in device development and manufacturing.

From the Molly® modular platform technology to the Needle Isolation Technology (NIT®)-integrated Maggie® 5.0 autoinjector, our device solutions – which will be featured in our booth – continue to evolve in parallel to industry advances and new drug formulations. Molly autoinjectors, in particular, have evolved further since our last launch. Thanks to its robust modular technology, Molly now allows a more versatile offering, including increased flexibility with viewing windows, syringes, and springs.

Beyond devices, SHL has also been actively developing initiatives around digital healthcare. As digital health becomes increasingly important, we set out to develop integrated platforms and drug delivery systems – backed by data – to capitalize the benefits of digital healthcare for the stakeholders while ensuring its accessibility to the patients in need.

Discover all of the exciting developments from SHL by engaging with our team members and digital health experts on-site. Contact SHL today to book a meeting with us during the event.

Where: Nice Acropolis Convention center, Nice, France

When: October 11-13

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News